Prevention of Contrast-Induced Nephropathy

Patient Management

The Kidney International recommends IV volume expansion with isotonic solutions (sodium chloride or sodium bicarbonate) for patients at risk of CI-AKI, and suggests that oral fluids alone are not sufficient for patients at increased risk of CI-AKI 1
For diabetic patients, insulin and dextrose infusion may be required for glycemic control, as recommended by the Kidney International 1
ACE inhibitors/ARBs can be continued, as recent studies show no increased risk, according to Kidney International 1

The American Heart Association recommends maintaining a target mean arterial pressure of ≥65 mmHg 2
Evaluate renal function using eGFR in all patients before the procedure, as recommended by the European Heart Journal 3
Renal function should be monitored after the procedure, and metformin should be withheld if renal function deteriorates post-procedure until renal function stabilizes 4

The European Society of Cardiology guidelines recommend withholding metformin for 48 hours after IV contrast administration in patients with impaired renal function, and restarting it only after confirming stable renal function, to minimize the risk of lactic acidosis, with a moderate to high strength of evidence 4, 5
Patients with normal renal function (eGFR >60 mL/min/1.73m²) are at low risk for lactic acidosis, while those with eGFR 30-60 mL/min/1.73m² are at moderate risk, and those with eGFR <30 mL/min/1.73m² are at high risk (contraindication for metformin) 4
Not checking renal function before restarting metformin can lead to increased risk of lactic acidosis, and it is recommended to always verify stable renal function before restarting the medication, with a high strength of evidence 4

Hydration protocols and monitoring for contrast-induced nephropathy are crucial in patients undergoing IV contrast administration, especially those with pre-existing renal impairment, with recommendations for isotonic saline at 1 mL/kg/hour for 12 hours pre-procedure and continued hydration for 24 hours post-procedure, with a reduced rate to 0.5 mL/kg/hour if cardiac function is compromised (EF <35% or NYHA >2) 4, 6, 3, 7
The minimum target urine output is 0.5 mL/kg/hour, and patients who fall below this target should receive an NS or LR 500 mL IV bolus over 30 minutes, with reassessment of urine output after 1 hour 8
Use of low-osmolar (LOCM) or iso-osmolar contrast media (IOCM) is recommended, with the lowest possible dose of contrast media, aiming for < 350 mL or < 4 mL/kg 7, 4, 3, 1, 9

Nephrotoxic medications (NSAIDs, aminoglycosides) should be temporarily suspended before and after the procedure, as recommended by the American College of Radiology and European guidelines 6, 10, 11, 9, 12
Consider prophylactic hemofiltration 6 hours before the procedure for patients with very severe CKD (GFR <30 mL/min/1.73m²) undergoing complex procedures (Class IIa, Level B), according to European guidelines 7, 4
Short-term, high-dose statin therapy (Class IIa, Level A) may be considered, as recommended by the European Society of Cardiology 4

For patients with eGFR <30 mL/min/1.73m², consider alternative imaging modalities, as suggested by the American College of Radiology 6
Consider radial access for coronary procedures to reduce hemorrhagic complications, as recommended by the European Heart Journal 3

Avoid indwelling urinary catheters when possible to reduce infection risk, and remove them as soon as the patient is medically stable, with consideration of intermittent catheterization if post-void residual is >100 mL, as recommended by the American Heart Association 13
If metformin-associated lactic acidosis is suspected, discontinue metformin immediately, provide supportive care in a hospital setting, and consider prompt hemodialysis to correct acidosis and remove accumulated metformin 11
Alternative glucose-controlling medications should be considered during metformin withdrawal in patients with impaired renal function, as suggested by the European Journal of Nuclear Medicine and Molecular Imaging and European guidelines 11